Article and Video CATEGORIES

Cancer Journey

Search By

BRAF: A New Target to Treat in Lung Cancer
Author
GRACE Videos and Articles

ASCO 2015 Highlights 12

 

A study released at ASCO 2015 showed that the BRAF V600E mutation had a high response rate to combination therapy Tafinlar (dabrafenib) plus Mekinist (trametinib), which led the doctors to agree that BRAF testing in lung cancer should become commonplace.

[powerpress]

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Next Previous link

Previous PostNext Post